Lipid peroxidation in Down syndrome caused by regular trisomy 21, trisomy 21 by Robertsonian translocation and mosaic trisomy 21

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 1, 2007, Pages 59-62

  Casado, Ángela ^a   López Fernández, Ma Encarnación ^a   Ruíz, Rocío ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Down syndrome; Free radicals; Lipid peroxidation; Malondialdehyde; Oxidative stress

Indexed keywords

MALONALDEHYDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME ANALYSIS; DIPLOIDY; DOWN SYNDROME; ERYTHROCYTE; FEMALE; HUMAN; INFANT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MOSAICISM; NEWBORN; PRIORITY JOURNAL; ROBERTSONIAN CHROMOSOME TRANSLOCATION; TRISOMY 21;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; ERYTHROCYTES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MOSAICISM; OXIDATIVE STRESS; TRANSLOCATION, GENETIC; TRISOMY;

ROBERTSONIA;

EID: 33846522388     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.011     Document Type: Article

References (24)

1. Lejeune J, Gautier M, Turpin R. Etude des chromosomes somatiques de 9 enfants mongoliens. CR Acad Sci Paris 1959;248:1721-8.
2. Hook EB. Down's syndrome-frequency in human populations and factors pertinent to variation in rates. In: de la Cruz FF, Gerald PS, editors. Trisomy 21 (Down syndrome): research perspectives. Baltimore: University Park Press, 1981:3-68.
3. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1-14.
4. Halliwell B, Gutteridge JM. Free radicals in biology and medicine. Oxford: Clarendon Press, 1985.
5. Draper HH, Dhanakoti SN, Hadley M, Piche LA. Malondialdehyde in biological systems. In: Chow CK, editor. Cellular antioxidant defense mechanism. Boca Raton, FL: CRC Press, 1988:97-100.
6. Ambrosio G, Flaherty JJ. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused heart. J Clin Invest 1991;87:2056-66.
7. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987;33:214-20.
8. Bull AW, Marnett LJ. Determination of malondialdehyde by ion-pairing high-performance liquid chromatography. Anal Biochem 1985;149:284-90.
9. Esterbauer H, Lang J, Zadravec S, Slater F. Detection of malondialdehyde by high-performance liquid chromatography. In: Packer L, editor. Oxygen radical in biological systems. Methods in enzymology, vol 105. London: Academic Press, 1984:319-27.
10. Gil P, Fariñas F, Casado A, López-Fernández ME. Malondialdehyde: a possible marker of ageing. Gerontology 2002;48:209-14.
11. Inal ME, Kanbak G, Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta 2001;305:75-80.
12. Inal ME, Sunal E, Kanbak G, Zeytinoglu S. Effects of postmenopausal hormone replacement and α-tocopherol on the lipid profiles and antioxidant status. Clin Chim Acta 1997;268:21-9.
13. Rodriguez MM, Ruiz TA. Homeostasis between lipid peroxidation and antioxidant enzyme activities in healthy human aging. Mech Ageing Dev 1992;66:213-22.
14. Nohl H. Involvement of free radicals in ageing: a consequence or cause senescence. Br Med Bull 1991;49:653-67.
15. Jovanovic SV, Clements D, MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 1998;25:1044-8.
16. Muchová J, Sustrová M, Garaiová I, Liptákova A, Blazicek P, Kvasnicka P, et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome. Free Radic Biol Med 2001;31:499-508.
17. Zitnanova I, Korytar P, Sobotová H, Horáková L, Sustrová M, Pueschel S, et al. Markers of oxidative stress in children with Down syndrome. Clin Chem Lab Med 2006;44:306-10.
18. Srivastava S, Chandra A, Wang LF, Seifert WE, Dague BB, Ansari NH, et al. Metabolism of the lipid peroxidation product 4-hydroxy-trans-nonenal in isolated perfused rat heart. J Biol Chem 1998;273:10893-900.
19. Garber P, Sinet P, Lejeune J. Copper zinc SOD activity in trisomy 21 by translocation. Lancet 1979;ii:914-8.
20. Jeziorowska A, Jakubowski L, Armatys A, Kaluzewski B. Copper/zinc superoxide dismutase (SOD-1) activity in regular trisomy 21, trisomy 21 by translocation and mosaic trisomy 21. Clin Genet 1982;22:160-4.
21. De la Torre R, Casado A, López-Fernández ME, Carrascosa D, Ramirez V, Sáez J. Overexpression of copper-zinc superoxide dismutase in trisomy 21. Experientia 1996;52:871-3.
22. Yim MB, Chock PB, Stadman ER. Enzyme function of copper, zinc superoxide dismutase as a free radical generator. J Biol Chem 1993;268:4099-105.
23. Yim MB, Chock PB, Stadman ER. Copper, zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide. Proc Natl Acad Sci USA 1990;87:5006-10.
24. Pastor MC, Sierra C, Dolade M, Navarro E, Brandi N, Cabre E, et al. Antioxidant enzymes and fatty acid status in erythrocytes of Down syndrome patients. Clin Chem 1998;44:924-9.